Literature DB >> 12406104

Successful umbilical cord blood transplantation in a child with dyskeratosis congenita after a fludarabine-based reduced-intensity conditioning regimen.

Bruno Nobili, Gabriele Rossi, Piero De Stefano, Marco Zecca, Giovanna Giorgiani, Silverio Perrotta, Anna Canazzio, Franco Locatelli.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12406104     DOI： 10.1046/j.1365-2141.2002.03835_2.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN： 0007-1048            Impact factor:   6.998


× No keyword cloud information.
  9 in total

1.  Outcomes after related and unrelated umbilical cord blood transplantation for hereditary bone marrow failure syndromes other than Fanconi anemia.

Authors:  Renata Bizzetto; Carmen Bonfim; Vanderson Rocha; Gérard Socié; Franco Locatelli; Kawah Chan; Oscar Ramirez; Joel Stein; Samir Nabhan; Eliana Miranda; Jakob Passweg; Carmino Antonio de Souza; Eliane Gluckman
Journal:  Haematologica       Date:  2010-11-11       Impact factor: 9.941

2.  Optimization of therapy for severe aplastic anemia based on clinical, biologic, and treatment response parameters: conclusions of an international working group on severe aplastic anemia convened by the Blood and Marrow Transplant Clinical Trials Network, March 2010.

Authors:  Michael A Pulsipher; Neal S Young; Jakub Tolar; Antonio M Risitano; H Joachim Deeg; Paolo Anderlini; Rodrigo Calado; Seiji Kojima; Mary Eapen; Richard Harris; Phillip Scheinberg; Sharon Savage; Jaroslaw P Maciejewski; Ramon V Tiu; Nancy DiFronzo; Mary M Horowitz; Joseph H Antin
Journal:  Biol Blood Marrow Transplant       Date:  2010-10-27       Impact factor: 5.742

3.  Characterization of primitive hematopoietic cells from patients with dyskeratosis congenita.

Authors:  Frederick D Goldman; Geraldine Aubert; Al J Klingelhutz; Mark Hills; Sarah R Cooper; Wendy S Hamilton; Annette J Schlueter; Karen Lambie; Connie J Eaves; Peter M Lansdorp
Journal:  Blood       Date:  2008-02-29       Impact factor: 22.113

Review 4.  Evaluation and Management of Hematopoietic Failure in Dyskeratosis Congenita.

Authors:  Suneet Agarwal
Journal:  Hematol Oncol Clin North Am       Date:  2018-05-28       Impact factor: 3.722

Review 5.  Further delineation of the congenital form of X-linked dyskeratosis congenita (Hoyeraal-Hreidarsson syndrome).

Authors:  Yves Sznajer; Clarisse Baumann; Albert David; Hubert Journel; Didier Lacombe; Yves Perel; Pascale Blouin; Jean-François Segura; Jean-Pierre Cezard; Michel Peuchmaur; Tomy Vulliamy; Inderjeet Dokal; Alain Verloes
Journal:  Eur J Pediatr       Date:  2003-09-30       Impact factor: 3.183

Review 6.  The genetics and clinical manifestations of telomere biology disorders.

Authors:  Sharon A Savage; Alison A Bertuch
Journal:  Genet Med       Date:  2010-12       Impact factor: 8.822

7.  Disease-specific hematopoietic cell transplantation: nonmyeloablative conditioning regimen for dyskeratosis congenita.

Authors:  A C Dietz; P J Orchard; K S Baker; R H Giller; S A Savage; B P Alter; J Tolar
Journal:  Bone Marrow Transplant       Date:  2010-04-12       Impact factor: 5.174

8.  Transplantation for congenital bone marrow failure syndromes.

Authors:  Kenji Morimoto; Theodore B Moore; Gary Schiller; Kathleen M Sakamoto
Journal:  Bone Marrow Res       Date:  2010-11-29

Review 9.  Molecular insight of dyskeratosis congenita: Defects in telomere length homeostasis.

Authors:  Saeed Dorgaleleh; Karim Naghipoor; Zahra Hajimohammadi; Farzad Dastaviz; Morteza Oladnabi
Journal:  J Clin Transl Res       Date:  2022-01-03
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.